SEDAR-SEMICYUC consensus on the management of haemostasis disorders in severe COVID-19 patients
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2020 |
|---|---|
| Enthalten in: |
Medicina intensiva - (2020) vom: 06. Sept. |
| Sprache: |
Englisch |
|---|
| Weiterer Titel: |
Consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes COVID-19 graves |
|---|
| Beteiligte Personen: |
Llau, J V [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 22.02.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.medin.2020.08.007 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM315939524 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315939524 | ||
| 003 | DE-627 | ||
| 005 | 20240229142909.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.medin.2020.08.007 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1303.xml |
| 035 | |a (DE-627)NLM315939524 | ||
| 035 | |a (NLM)33023765 | ||
| 035 | |a (PII)S0210-5691(20)30272-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Llau, J V |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SEDAR-SEMICYUC consensus on the management of haemostasis disorders in severe COVID-19 patients |
| 246 | 3 | 3 | |a Consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes COVID-19 graves |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 22.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 650 | 4 | |a Letter | |
| 700 | 1 | |a Ferrandis, R |e verfasserin |4 aut | |
| 700 | 1 | |a Sierra, P |e verfasserin |4 aut | |
| 700 | 1 | |a Hidalgo, F |e verfasserin |4 aut | |
| 700 | 1 | |a Cassinello, C |e verfasserin |4 aut | |
| 700 | 1 | |a Gómez-Luque, A |e verfasserin |4 aut | |
| 700 | 1 | |a Quintana, M |e verfasserin |4 aut | |
| 700 | 1 | |a Amezaga, R |e verfasserin |4 aut | |
| 700 | 1 | |a Geroi, M |e verfasserin |4 aut | |
| 700 | 1 | |a Serrano, A |e verfasserin |4 aut | |
| 700 | 1 | |a Marcos, P |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Medicina intensiva |d 2017 |g (2020) vom: 06. Sept. |w (DE-627)NLM25948640X |x 2173-5727 |7 nnns |
| 773 | 1 | 8 | |g year:2020 |g day:06 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.medin.2020.08.007 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2020 |b 06 |c 09 | ||